These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 32658620)
1. Talk about micromanaging! Role of microRNAs in intestinal barrier function. Al-Sadi R; Engers J; Abdulqadir R Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G170-G174. PubMed ID: 32658620 [TBL] [Abstract][Full Text] [Related]
2. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients. Schlegel N; Boerner K; Waschke J Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327 [TBL] [Abstract][Full Text] [Related]
3. MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease. Chen T; Xue H; Lin R; Huang Z Biochem Biophys Res Commun; 2017 Apr; 486(1):6-13. PubMed ID: 28153728 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350 [TBL] [Abstract][Full Text] [Related]
5. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect? de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020 [TBL] [Abstract][Full Text] [Related]
7. Role of MiRNAs in Inflammatory Bowel Disease. Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials. Tili E; Michaille JJ; Piurowski V; Rigot B; Croce CM Curr Opin Pharmacol; 2017 Dec; 37():142-150. PubMed ID: 29154194 [TBL] [Abstract][Full Text] [Related]
9. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Michielan A; D'Incà R Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514 [TBL] [Abstract][Full Text] [Related]
11. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Lee SH Intest Res; 2015 Jan; 13(1):11-8. PubMed ID: 25691839 [TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Wang H; Chao K; Ng SC; Bai AH; Yu Q; Yu J; Li M; Cui Y; Chen M; Hu JF; Zhang S Genome Biol; 2016 Mar; 17():58. PubMed ID: 27029486 [TBL] [Abstract][Full Text] [Related]
13. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
14. Autophagy and tight junction proteins in the intestine and intestinal diseases. Hu CA; Hou Y; Yi D; Qiu Y; Wu G; Kong X; Yin Y Anim Nutr; 2015 Sep; 1(3):123-127. PubMed ID: 29767173 [TBL] [Abstract][Full Text] [Related]
15. miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease. Xiao X; Mao X; Chen D; Yu B; He J; Yan H; Wang J Front Immunol; 2022; 13():868229. PubMed ID: 35493445 [TBL] [Abstract][Full Text] [Related]
16. Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases. Cheng T; Xu C; Shao J Clin Exp Med; 2023 Aug; 23(4):1015-1031. PubMed ID: 36385416 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994 [TBL] [Abstract][Full Text] [Related]
18. Mast cells-derived MiR-223 destroys intestinal barrier function by inhibition of CLDN8 expression in intestinal epithelial cells. Li M; Zhao J; Cao M; Liu R; Chen G; Li S; Xie Y; Xie J; Cheng Y; Huang L; Su M; Xu Y; Zheng M; Zou K; Geng L; Xu W; Gong S Biol Res; 2020 Mar; 53(1):12. PubMed ID: 32209121 [TBL] [Abstract][Full Text] [Related]
19. Regulation of Intestinal Epithelial Barrier Function by Long Noncoding RNA Wang JY; Cui YH; Xiao L; Chung HK; Zhang Y; Rao JN; Gorospe M; Wang JY Mol Cell Biol; 2018 Jul; 38(13):. PubMed ID: 29632078 [TBL] [Abstract][Full Text] [Related]
20. The Increase of miR-195-5p Reduces Intestinal Permeability in Ulcerative Colitis, Modulating Tight Junctions' Expression. Scalavino V; Piccinno E; Bianco G; Schena N; Armentano R; Giannelli G; Serino G Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]